Larvol Delta - Clinical-Study-to-Evaluate-the-Safety-and-Efficacy-of-IM21-CART-Cells-in-the-Treatment-of-Elderly-Patients-With-Relapsed-or-Refractory-Multiple-Myeloma

IM21 CART - Immunochina Pharma

http://clinicaltrials.gov/ct2/show/NCT04537442

Sep 3, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev